BACKGROUND: Although physical activity has been associated with reduced breast cancer risk, whether this association varies across breast cancer subtypes or is modified by reproductive and lifestyle factors is unclear. METHODS: We examined physical activity in relation to postmenopausal breast cancer risk in 182,862 U.S. women in the NIH-AARP Diet and Health Study. Physical activity was assessed by self-report at baseline (1995-1996), and 6,609 incident breast cancers were identified through December 31, 2003. Cox regression was used to estimate the relative risk (RR) and 95% confidence interval (95% CI) of postmenopausal breast cancer overall and by tumor characteristics. Effect modification by select reproductive and lifestyle factors was also explored. RESULTS: In multivariate models, the most active women experienced a 13% lower breast cancer risk versus inactive women (RR, 0.87; 95% CI, 0.81-0.95). This inverse relation was not modified by tumor stage or histology but was suggestively stronger for estrogen receptor (ER)-negative (RR, 0.75; 95% CI, 0.54-1.04) than ER-positive (RR, 0.97; 95% CI, 0.84-1.12) breast tumors and was suggestively stronger for overweight/obese (RR, 0.86; 95% CI, 0.77-0.96) than lean (RR, 0.95; 95% CI, 0.87-1.05) women. The inverse relation with physical activity was also more pronounced among women who had never used menopausal hormone therapy and those with a positive family history of breast cancer than their respective counterparts. CONCLUSIONS: Physical activity was associated with reduced postmenopausal breast cancer risk, particular to ER-negative tumors. These results, along with heterogeneity in the physical activity-breast cancer relation for subgroups of menopausal hormone therapy use and adiposity, indicate that physical activity likely influences breast cancer risk via both estrogenic and estrogen-independent mechanisms.
BACKGROUND: Although physical activity has been associated with reduced breast cancer risk, whether this association varies across breast cancer subtypes or is modified by reproductive and lifestyle factors is unclear. METHODS: We examined physical activity in relation to postmenopausal breast cancer risk in 182,862 U.S. women in the NIH-AARP Diet and Health Study. Physical activity was assessed by self-report at baseline (1995-1996), and 6,609 incident breast cancers were identified through December 31, 2003. Cox regression was used to estimate the relative risk (RR) and 95% confidence interval (95% CI) of postmenopausal breast cancer overall and by tumor characteristics. Effect modification by select reproductive and lifestyle factors was also explored. RESULTS: In multivariate models, the most active women experienced a 13% lower breast cancer risk versus inactive women (RR, 0.87; 95% CI, 0.81-0.95). This inverse relation was not modified by tumor stage or histology but was suggestively stronger for estrogen receptor (ER)-negative (RR, 0.75; 95% CI, 0.54-1.04) than ER-positive (RR, 0.97; 95% CI, 0.84-1.12) breast tumors and was suggestively stronger for overweight/obese (RR, 0.86; 95% CI, 0.77-0.96) than lean (RR, 0.95; 95% CI, 0.87-1.05) women. The inverse relation with physical activity was also more pronounced among women who had never used menopausal hormone therapy and those with a positive family history of breast cancer than their respective counterparts. CONCLUSIONS: Physical activity was associated with reduced postmenopausal breast cancer risk, particular to ER-negative tumors. These results, along with heterogeneity in the physical activity-breast cancer relation for subgroups of menopausal hormone therapy use and adiposity, indicate that physical activity likely influences breast cancer risk via both estrogenic and estrogen-independent mechanisms.
Authors: Evelyn M Monninkhof; Sjoerd G Elias; Femke A Vlems; Ingeborg van der Tweel; A Jantine Schuit; Dorien W Voskuil; Flora E van Leeuwen Journal: Epidemiology Date: 2007-01 Impact factor: 4.822
Authors: A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis Journal: Am J Epidemiol Date: 2001-12-15 Impact factor: 4.897
Authors: Brian L Sprague; Amy Trentham-Dietz; Polly A Newcomb; Linda Titus-Ernstoff; John M Hampton; Kathleen M Egan Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-02 Impact factor: 4.254
Authors: Caroline E Boeke; A Heather Eliassen; Hannah Oh; Donna Spiegelman; Walter C Willett; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2014-03-30 Impact factor: 4.872
Authors: Hannah Arem; Steven C Moore; Alpa Patel; Patricia Hartge; Amy Berrington de Gonzalez; Kala Visvanathan; Peter T Campbell; Michal Freedman; Elisabete Weiderpass; Hans Olov Adami; Martha S Linet; I-Min Lee; Charles E Matthews Journal: JAMA Intern Med Date: 2015-06 Impact factor: 21.873
Authors: Megan S Rice; Shelley S Tworoger; Susan E Hankinson; Rulla M Tamimi; A Heather Eliassen; Walter C Willett; Graham Colditz; Bernard Rosner Journal: Breast Cancer Res Treat Date: 2017-07-12 Impact factor: 4.872
Authors: Lauren E McCullough; Sybil M Eng; Patrick T Bradshaw; Rebecca J Cleveland; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Cancer Date: 2012-06-25 Impact factor: 6.860
Authors: Xuehong Zhang; A Heather Eliassen; Rulla M Tamimi; Aditi Hazra; Andrew H Beck; Myles Brown; Laura C Collins; Bernard Rosner; Susan E Hankinson Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04-08 Impact factor: 4.254
Authors: Qian Xiao; Hannah P Yang; Nicolas Wentzensen; Albert Hollenbeck; Charles E Matthews Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-08-21 Impact factor: 4.254
Authors: Tricia M Peters; Steven C Moore; Gretchen L Gierach; Nicholas J Wareham; Ulf Ekelund; Albert R Hollenbeck; Arthur Schatzkin; Michael F Leitzmann Journal: BMC Cancer Date: 2009-10-01 Impact factor: 4.430